Michael G. Espey, Ph.D., M.T.

Deputy Associate Director

Dr. Espey conducts strategic planning and manages support for research in the imaging sciences and its application across scales to both improve treatment and advance our understanding of biological processes for the benefit of patients with cancers. He specializes in creating topically focused research programs and consortia with national impact that facilitate interdisciplinary cooperation and collaboration. Outreach to promote success through grantsmanship and workforce development are key areas of prioritization. Dr. Espey is board certified in Clinical Pathology with Medical Technologist experience in Immunology, Organ Transplant, Hematology, Microbiology-Virology, and Transfusion Medicine at the University of Iowa Hospital, Georgetown University Hospital, and the NIH Clinical Center. He received his PhD with distinction from Georgetown University in Biochemistry and Physiology for work on intermediate metabolism in the immune system. As an NIH intramural staff scientist in both NCI and NIDDK, Dr. Espey conducted research that bridged biochemistry, neuropharmacology, immunology & infectious disease, metabolism, cancer cell biology, and radiation biology. He has specialized expertise in redox biochemistry in relation to cancer biology and therapeutic interventions with strong interests in cellular imaging and biophysical approaches. He was the NIH FAES Professor for Molecular and Cellular Biology. Dr. Espey has authored over 150 scientific research articles, reviews, and book chapters across diverse fields of study with approx. 20,000 citations. His programmatic experience spans the NCI Office of the Director, Division of Cancer Biology, and Division of Cancer Treatment and Diagnosis.